Spyre Therapeutics
SYRE
#2075
Rank
A$13.41 B
Marketcap
A$141.21
Share price
-4.26%
Change (1 day)
275.93%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): A-$4.08

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is A-$4.24. In 2025 the company made an earnings per share (EPS) of A-$3.10 an increase over its 2024 EPS that were of A-$5.63.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.0831.52%
2025A-$3.10-44.82%
2024A-$5.63